Metals as radio-enhancers in oncology: The industry perspective

2015 The Cancer Market Outlook to 2016, 2011 Peiffert, 2014, Treatment of hepatic metastases of colorectal cancer by robotic stereotactic radiation (Cyberknife®), J. Visc. Surg., 151, S45 Sharp, 2014, Vision 20/20: perspectives on automated image segmentation for radiotherapy, Med. Phys., 41, 050902, 10.1118/1.4871620 Brada, 2014, e89 Citrin, 2014, Altering the response to radiation: sensitizers and protectors, Semin. Oncol., 41, 848, 10.1053/j.seminoncol.2014.09.013 Pottier, 2014, New use of metals as nanosized radioenhancers, Anticancer Res., 34, 443 Coleman, 1999, Clinical radiosensitization: why it does and does not work, J. Clin. Oncol., 17, 1, 10.1200/JCO.1999.17.1.1 Leung, 2011, Irradiation of gold nanoparticles by x-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production, Med. Phys., 38, 624, 10.1118/1.3539623 Nam, 2013, Surface engineering of inorganic nanoparticles for imaging and therapy, Adv. Drug Deliv. Rev., 65, 622, 10.1016/j.addr.2012.08.015 Maeda, 2015, Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity, Adv. Drug Deliv. Rev., 10.1016/j.addr.2015.01.002 Albanese, 2014, Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles, ACS Nano, 8, 5515, 10.1021/nn4061012 van de Ven, 2012, Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution, J. Control. Release, 158, 148, 10.1016/j.jconrel.2011.10.021 Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nano Lett., 6, 662, 10.1021/nl052396o Nel, 2009, Understanding biophysicochemical interactions at the nano-bio interface, Nat. Mater, 8, 543, 10.1038/nmat2442 McMahon, 2011, Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy, Radiother. Oncol., 100, 412, 10.1016/j.radonc.2011.08.026 Berbeco, 2012, DNA damage enhancement from gold nanoparticles for clinical MV photon beams, Radiat. Res., 178, 604, 10.1667/RR3001.1 Marill, 2014, Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?, Radiat. Oncol., 9, 150, 10.1186/1748-717X-9-150 Maggiorella, 2012, Nanoscale radiotherapy with hafnium oxide nanoparticles, Future Oncol., 8, 1167, 10.2217/fon.12.96 Bonvalot, 2014, Phase I study of NBTXR3 nanoparticles, in patients with advanced soft tissue sarcoma (STS), J. Clin. Oncol., 32, 10.1200/jco.2014.32.15_suppl.10563 Eaton, 2015, Delivering nanomedicines to patients: a practical guide, Nanomedicine, 11, 983, 10.1016/j.nano.2015.02.004 Malinoski, 2014, The nanomedicines alliance: an industry perspective on nanomedicines, Nanomedicine, 10, 1819, 10.1016/j.nano.2014.07.003 Crist, 2013, Common pitfalls in nanotechnology: lessons learned from NCI׳s Nanotechnology Characterization Laboratory, Integr. Biol., 5, 66, 10.1039/C2IB20117H